000 | 01952 a2200529 4500 | ||
---|---|---|---|
005 | 20250514032041.0 | ||
264 | 0 | _c20020516 | |
008 | 200205s 0 0 eng d | ||
022 | _a0161-6420 | ||
024 | 7 |
_a10.1016/s0161-6420(02)01010-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFellman, Ronald L | |
245 | 0 | 0 |
_aComparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial. _h[electronic resource] |
260 |
_bOphthalmology _cMay 2002 |
||
300 |
_a998-1008 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Evaluation Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCloprostenol _xadministration & dosage |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlaucoma, Open-Angle _xdrug therapy |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntraocular Pressure _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOcular Hypertension _xdrug therapy |
650 | 0 | 4 | _aOphthalmic Solutions |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aSafety |
650 | 0 | 4 |
_aTimolol _xadministration & dosage |
650 | 0 | 4 | _aTravoprost |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aSullivan, E Kenneth | |
700 | 1 | _aRatliff, Marla | |
700 | 1 | _aSilver, Lewis H | |
700 | 1 | _aWhitson, Jess T | |
700 | 1 | _aTurner, F Darell | |
700 | 1 | _aWeiner, Alan L | |
700 | 1 | _aDavis, Alberta A | |
773 | 0 |
_tOphthalmology _gvol. 109 _gno. 5 _gp. 998-1008 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0161-6420(02)01010-2 _zAvailable from publisher's website |
999 |
_c11886050 _d11886050 |